Form 8-K · Current report
Snap-on 8-K, filed Jul 23, 2026
- Filed
- CIK
- 0000091440
- Accession no.
- 0000091440-26-000141
Summary
Snap-on reported second-quarter 2026 net sales of $1,235.1 million, up 4.7% year over year, and diluted earnings per share of $4.96 versus $4.72 a year earlier, with management citing growth in the U.S. Tools Group and in Asia Pacific and European hand tools operations. Chairman and CEO Nick Pinchuk said the company completed the acquisitions of Hi-Force Hydraulic Tools and Diesel Laptops during the quarter and expects 2026 capital expenditures of about $100 million and a full-year effective tax rate near 22%.
Key points
- Snap-on reported second-quarter 2026 net sales of $1,235.1 million, up 4.7% from a year earlier, with organic sales up 3.0%.
- Diluted EPS was $4.96 versus $4.72 a year earlier, and gross margin rose to 51.4% from 50.5%.
- Snap-on completed the acquisitions of Hi-Force Hydraulic Tools and Diesel Laptops during the quarter.
- Snap-on projected 2026 capital expenditures of about $100 million and a full-year effective tax rate of approximately 22%.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition On July 23, 2026, Snap-on Incorporated (the “Corporation”) issued a press release announcing results for its second quarter ended July 4, 2026. The text of the press release is furnished herewith as Exhibit 99 to this Current Report on Form 8-K. The press release contains cautionary statements identifying important factors that could cause actual results of the Corporation to differ materially from those described in any forward-looking statement of the Corporation. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.